Generated by AI
Fortress Biotech Inc. Preferred Stock 9.375% Perpetual is a type of preferred equity issued by Fortress Biotech Inc., a biopharmaceutical company engaged in the development and commercialization of prescription medications and therapeutic products. This financial instrument offers investors a fixed dividend yield of 9.375%, positioning it as a source of steady income. The "perpetual" nature of this preferred stock indicates it has no fixed maturity date, allowing dividends to be paid indefinitely as long as the issuing company remains solvent. Preferred stocks like this one often appeal to investors seeking stable returns, standing ahead of common equity in the capital structure during liquidation. Fortress Biotech operates across various sectors within the biotech industry, significantly impacting pharmaceutical innovation and therapeutic advancements. The preferred stock's distinctive high-dividend appeal underlines its importance in the market for investors prioritizing income over capital appreciation.
Website1111 Kane Concourse
Bay Harbor Islands, FL, 33154
United States
The latest articles about FBIOP.
Summary of Nov 12's posts. Generated by AI.
No summary yet.
No summary yet.
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 28th Annual Global Investment Conference. The prese
No summary yet.
Investors talking about FBIOP also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.